Abstract
Inhibition of microsomal oxidative drug metabolism by 1,4-bis (2-[(2-hydroxyethyl)amino]-ethylamino)-9,10-anthracenedione diacetate, a new antineoplastic agent.
E D Kharasch and R F Novak
Molecular Pharmacology September 1982, 22 (2) 471-478;
